Logo image of MGEN

Miragen Therapeutics Inc (MGEN) Stock Overview

USA - NASDAQ:MGEN -

23.01
-0.02 (-0.09%)
Last: 1/19/2021, 8:20:36 PM

MGEN Key Statistics, Chart & Performance

Key Statistics
Market Cap89.92M
Revenue(TTM)1.88M
Net Income(TTM)-30091000
Shares3.91M
Float47.88M
52 Week High34.05
52 Week Low4.67
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-10.65
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


MGEN short term performance overview.The bars show the price performance of MGEN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

MGEN long term performance overview.The bars show the price performance of MGEN in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of MGEN is 23.01 null. In the past month the price increased by 15.69%. In the past year, price increased by 58.14%.

Miragen Therapeutics Inc / MGEN Daily stock chart

MGEN Latest News, Press Relases and Analysis

5 years ago - By: Benzinga - Mentions: PI JUPW CGA EDIT ...
News Image
5 years ago - By: Analyst Ratings
News Image
5 years ago - By: Benzinga - Mentions: EYEG GTE FTFT ALRN ...
News Image
5 years ago - By: Zacks Investment Research - Mentions: ARNA EBS RGEN
News Image
5 years ago - By: InvestorPlace
News Image
5 years ago - By: Zacks Investment Research - Mentions: MRK EBS IOVA
News Image

About MGEN

Company Profile

Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.

Company Info

Miragen Therapeutics Inc

6200 LOOKOUT ROAD

BOULDER CO 80301

CEO: William S. Marshall

Phone: 720-643-5200

Miragen Therapeutics Inc / MGEN FAQ

Can you describe the business of Miragen Therapeutics Inc?

Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.


Can you provide the latest stock price for Miragen Therapeutics Inc?

The current stock price of MGEN is 23.01 null. The price decreased by -0.09% in the last trading session.


Does MGEN stock pay dividends?

MGEN does not pay a dividend.


What is the ChartMill technical and fundamental rating of MGEN stock?

MGEN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists MGEN stock?

MGEN stock is listed on the Nasdaq exchange.


MGEN Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to MGEN. When comparing the yearly performance of all stocks, MGEN is one of the better performing stocks in the market, outperforming 94.92% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MGEN Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MGEN. While MGEN seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MGEN Financial Highlights

Over the last trailing twelve months MGEN reported a non-GAAP Earnings per Share(EPS) of -10.65. The EPS decreased by -1.82% compared to the year before.


Industry RankSector Rank
PM (TTM) -1604%
ROA -91.65%
ROE N/A
Debt/Equity 0.2
Chartmill High Growth Momentum
EPS Q2Q%72.22%
Sales Q2Q%-100%
EPS 1Y (TTM)-1.82%
Revenue 1Y (TTM)-53.76%

MGEN Forecast & Estimates


Analysts
Analysts90
Price TargetN/A
EPS Next Y50.37%
Revenue Next YearN/A

MGEN Ownership

Ownership
Inst Owners49.6%
Ins Owners179.83%
Short Float %N/A
Short RatioN/A